Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
09/2012
09/19/2012CN101641091B Tamibarotene capsule preparation
09/19/2012CN101554461B Medicine for treating psoriasis and preparation method of capsule thereof
09/19/2012CN101537037B Amaranth berberine tablet and preparation method thereof
09/19/2012CN101480397B Cefixime orally disintegrating tablet and preparation method thereof
09/19/2012CN101472573B Reduced coenzyme Q10-containing composition and method for producing the same
09/19/2012CN101322739B Prescription of Chinese medicine health care capsules mixed with nucleotide and aminoacid and preparing technique
09/19/2012CN101297968B Preparation of pig serum immunoglobulin microsphere novel dosage form
09/19/2012CN101219115B Sustained drug-release particles and process for producing the same
09/19/2012CN101027077B Ejection liquid, ejection device, ejection cartridge, and method of making droplets from liquid
09/18/2012US8269040 O-desmethylvenlafaxine succinate; tablet, capsule; sustained release; hydroxypropylmethyl cellulose rate controlling polymer; microcrystalline cellulose binder; depression, bipolar and manic disorders, attention deficit disorder, attention deficit disorder with hyperactivity, Parkinson's disease
09/18/2012US8268892 Isomers of 2-(diphenylmethylsulfinyl)acetamide; therapy for attention deficit disorders; solid dosage form
09/18/2012US8268804 Minocycline oral dosage forms for the treatment of acne
09/18/2012US8268790 Dermatalogical formulations
09/18/2012US8268367 Topical herbal formulation for treatment of acne and skin disorders
09/18/2012US8268359 Organic polymer-inorganic fine particle antimicrobial composites and uses thereof
09/18/2012US8268358 Use of simple amino acids to form porous particles
09/18/2012US8268357 Processes for the preparation of lipophilic drug delivery vehicles
09/18/2012US8268356 Aqueous film coating solution, film coated granule and tablet using the same
09/18/2012US8268355 Silica particle comprising an organolanthanide compound, preparation process therefor and uses thereof
09/18/2012US8268354 Sonic low pressure spray drying
09/18/2012US8268353 Polymer latex compound
09/18/2012US8268352 Modified release composition for highly soluble drugs
09/18/2012US8268351 time-release agents comprising water-swellable matrix cores containing estrogen derivative extracted from animals surrounded by film-forming coatings
09/18/2012US8268350 Binders for tablets with high strength based on finely divided vinyllactam polymers, the production and use thereof
09/18/2012US8268349 Solid pharmaceutical dosage form
09/18/2012US8268348 Combinations and modes of administration of therapeutic agents and combination therapy
09/18/2012US8268347 Dual action, inhaled formulations providing both an immediate and sustained release profile
09/18/2012US8268345 Multipurpose hydrogel compositions and products
09/18/2012US8268344 Particle-containing complex porous materials
09/18/2012US8268343 Non-hormonal vaginal contraceptive
09/18/2012US8268342 Biodegradable polymer scaffold and process for preparation thereof
09/18/2012US8268341 Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
09/18/2012US8268337 Nontoxic killer of E. coli and other problem microorganisms
09/18/2012US8268334 Aqueous acidic hard surface cleaning and disinfecting compositions
09/18/2012US8268333 Orally administered agent and an orally administered agent/supporting substrate complex
09/18/2012US8268332 Method for dermatological treatment using chromophores
09/18/2012US8268323 Conformationally stabilized HIV envelope immunogens
09/18/2012US8268292 Obovatol having anti-anxiety activity
09/18/2012US8268240 Ciclesonide-containing sterile aqueous suspension
09/18/2012US8267921 Manually operable portable infusion device
09/18/2012US8267920 Methods and systems for neural maintenance and regeneration
09/18/2012US8267915 Dual well port device
09/18/2012US8267907 Device and method for exothermic treatment of eyelid diseases
09/18/2012US8267906 Transdermal delivery apparatus and method
09/18/2012US8267905 Apparatus and method for delivery of therapeutic and other types of agents
09/18/2012CA2561109C Gastric retention system
09/18/2012CA2549516C Percutaneous absorption-type pharmaceutical preparation
09/18/2012CA2532487C Multiparticle pharmaceutical dosage form containing a mucoadhesively formulated peptide or protein active substances, and a method for producing said pharmaceutical dosage form
09/18/2012CA2531832C Powdery formulations for inhalation, containing a novel anticholinergic agent
09/18/2012CA2517120C Pharmaceutical composition containing platinum complex as active substance and method of manufacturing thereof
09/18/2012CA2515259C Use of acetylsalicylic acid for the treatment of hemorrhoidal disease
09/18/2012CA2511185C A physically and chemically stable nicotine-containing particulate material
09/18/2012CA2507002C Solid drug for oral use
09/18/2012CA2493604C Patch containing fentanyl for mucous membrane of oral cavity
09/18/2012CA2493165C Oral composition with enhanced organoleptic properties comprising an enzyme and cyclodextrin
09/18/2012CA2492156C Tablet composition containing kampo medicinal extract and its manufacturing process
09/18/2012CA2480226C Stable pharmaceutical composition containing factor viii
09/18/2012CA2477288C Biodegradable polymeric material for biomedical applications
09/18/2012CA2470463C Tooth whitening products and methods of making the same
09/18/2012CA2461896C Injections for eye tissues containing drug bonded to polyethylene glycol
09/18/2012CA2388733C Food supplement for increasing lean mass and strength
09/18/2012CA2378943C Super-active porcine growth hormone releasing hormone analog
09/18/2012CA2226013C Preparations and methods for the treatment of t cell mediated diseases
09/13/2012WO2012122544A2 Protein nanoparticle dispersions
09/13/2012WO2012122535A2 Stable formulations for parenteral injection of peptide drugs
09/13/2012WO2012122493A1 Lipid based clopidogrel compositions, methods, and uses
09/13/2012WO2012122313A2 Targeted nanocarrier systems for delivery of actives across biological membranes
09/13/2012WO2012122163A1 Microneedle devices and methods
09/13/2012WO2012122162A1 Microneedle devices and methods
09/13/2012WO2012121977A2 Dodecafluoropentane emulsion as a stroke and ischemia therapy
09/13/2012WO2012121971A2 Locally released growth factors to mediate motor recovery after stroke
09/13/2012WO2012121798A2 Thiol-containing compounds for the removal of elements from tissues and formulations therefor
09/13/2012WO2012121758A1 Melt-extruded solid dispersions containing an apoptosis-inducing agent
09/13/2012WO2012121528A2 Magnetic nanocomposite specific for thyroid cancer and use thereof
09/13/2012WO2012121523A2 Process for preparing pharmaceutical formulation in form of antioxidant-free solution for injection containing pemetrexed or its salt
09/13/2012WO2012121461A1 Stable fast-dissolving film formulation for oral dosage form
09/13/2012WO2012121395A1 Cholesterol-dependent cytolysin variant and use thereof in dds
09/13/2012WO2012121202A1 Tablet-type composition for oral administration and method for producing same
09/13/2012WO2012121095A1 Enteral nutrient
09/13/2012WO2012120522A1 A taste masked chewable tablet of sildenafil
09/13/2012WO2012120516A1 Soy protein-based structures and uses thereof
09/13/2012WO2012120365A1 Stable pharmaceutical composition comprising ethinyl estradiol
09/13/2012WO2012120338A1 Method for the preparaton of a levothyroxine solution
09/13/2012WO2012120337A1 Aqueous paracetamol compositions and method of preparation
09/13/2012WO2012120328A1 Formulation comprising phenylaminopyrimidine derivative as active agent
09/13/2012WO2012120320A1 Herbal solid formulation and process for preparing the same
09/13/2012WO2012120284A1 Use of glycopyrrolate for treating tachycardia
09/13/2012WO2012120139A1 Implantable bio-resorbable polymer charged with fragile macromolecules
09/13/2012WO2012120082A1 Adenosine and derivatives thereof for use in pain therapy
09/13/2012WO2012120043A2 Method for forming drops of a first phase dispersed in a second phase substantially immiscible with the first phase
09/13/2012WO2012120040A1 Pharmaceutical compositions comprising metformin and a dpp-4 inhibitor or a sglt-2 inhibitor
09/13/2012WO2012119997A1 Pharmaceutical formulation for producing rapidly disintegrating tablets
09/13/2012WO2012119980A1 Particles containing a growth factor, and uses thereof
09/13/2012WO2012119907A1 Method of protecting biologically active substances against denaturation
09/13/2012WO2012119781A2 Novel lipids, phospholipids, phospholipid and lipid compositions and their use
09/13/2012WO2012119780A2 Novel lipids and novel phospholipids structures
09/13/2012WO2012119729A1 Semisolid aqueous pharmaceutical composition containing tapentadol
09/13/2012WO2012119728A1 Parenteral administration of tapentadol
09/13/2012WO2012119727A1 Aqueous pharmaceutical formulation of tapentadol for oral administration
09/13/2012WO2012119560A1 Preparation method for extractive of jinxuan hemorrhoid washing powder botanicals